Glaucoma screening study for people aged 55 to 65
Part of Eyes & vision clinical trials.
This trial offers eye screening for glaucoma in adults between 55 and 65 who live in specific local healthcare areas. The goal is to see how well the screening process works and improves identification of people who may have glaucoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 55 and 65 years old
- Live in the specified areas: ACES Lisbon Norte or ACES Alto Minho
- Be registered with your local primary care service in one of those areas
- Be willing to sign informed consent to take part in the screening
- Have an eye test image taken as part of the screening (image quality can affect some comparisons)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new algorithm to help screen for glaucoma in people of African descent. It aims to improve early detection and diagnosis.
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
This trial uses an AI tool to screen for glaucoma at community health centers. If you qualify, you will get a free eye check to catch glaucoma early and help researchers improve screening for high-risk groups.
This study uses a special imaging test (OCT angiography) to look at blood flow around the optic nerve in people with advanced glaucoma. It aims to better understand how glaucoma affects eye circulation, which may help improve future care.
This study tests whether offering eye exams at a health center helps find glaucoma early in people who are at higher risk. It may help you catch vision problems before they get worse.
This trial uses an artificial intelligence (AI) program to screen for glaucoma in people who have a family history of the disease. It aims to catch glaucoma early, when it can be treated more effectively.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.